The safety of a low-protein diet in older adults with advanced chronic kidney disease.

IF 4.8 2区 医学 Q1 TRANSPLANTATION Nephrology Dialysis Transplantation Pub Date : 2024-10-30 DOI:10.1093/ndt/gfae077
Karin Windahl, Nicholas C Chesnaye, Gerd Faxén Irving, Peter Stenvinkel, Tora Almquist, Maarit Korkeila Lidén, Christiane Drechsler, Maciej Szymczak, Magdalena Krajewska, Esther de Rooij, Claudia Torino, Gaetana Porto, Fergus J Caskey, Christoph Wanner, Kitty J Jager, Friedo W Dekker, Marie Evans
{"title":"The safety of a low-protein diet in older adults with advanced chronic kidney disease.","authors":"Karin Windahl, Nicholas C Chesnaye, Gerd Faxén Irving, Peter Stenvinkel, Tora Almquist, Maarit Korkeila Lidén, Christiane Drechsler, Maciej Szymczak, Magdalena Krajewska, Esther de Rooij, Claudia Torino, Gaetana Porto, Fergus J Caskey, Christoph Wanner, Kitty J Jager, Friedo W Dekker, Marie Evans","doi":"10.1093/ndt/gfae077","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>A low-protein diet (LPD) is recommended to patients with advanced chronic kidney disease (CKD), whereas geriatric guidelines recommend a higher amount of protein. The aim of this study was to evaluate the safety of LPD treatment in older adults with advanced CKD.</p><p><strong>Methods: </strong>The EQUAL study is a prospective, observational study including patients ≥65 years of age with an incident estimated glomerular filtration rate <20 ml/min/1.73 m2 in six European countries with follow-up through 6 years. Nutritional status was assessed by a 7-point subjective global assessment (SGA) every 3-6 months. Prescribed diet (g protein/kg of bodyweight) was recorded on every study visit; measured protein intake was available in three countries. Time to death and decline in nutritional status (SGA decrease of ≥2 points) were analysed using marginal structural models with dynamic inverse probability of treatment and censoring weights.</p><p><strong>Results: </strong>Of 1738 adults (631 prescribed LPD at any point during follow-up), there were 1319 with repeated SGA measurements, of which 267 (20%) decreased in SGA ≥2 points and 565 (32.5%) who died. There was no difference in survival or decrease in nutritional status for patients prescribed a LPD ≤0.8 g/kg ideal bodyweight {odds ratio [OR] for mortality 1.15 [95% confidence interval (CI) 0.86-1.55)] and OR for decrease in SGA 1.11 [95% CI 0.74-1.66]} in the adjusted models. In patients prescribed a LPD <0.6 g/kg ideal bodyweight, the results were similar. There was a significant interaction with LPD and older age >75 years, lower SGA and higher comorbidity burden for both mortality and nutritional status decline.</p><p><strong>Conclusions: </strong>In older adults with CKD approaching end-stage kidney disease, a traditional LPD prescribed and monitored according to routine clinical practice in Europe appears to be safe.</p>","PeriodicalId":19078,"journal":{"name":"Nephrology Dialysis Transplantation","volume":" ","pages":"1867-1875"},"PeriodicalIF":4.8000,"publicationDate":"2024-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nephrology Dialysis Transplantation","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/ndt/gfae077","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"TRANSPLANTATION","Score":null,"Total":0}
引用次数: 0

Abstract

Background: A low-protein diet (LPD) is recommended to patients with advanced chronic kidney disease (CKD), whereas geriatric guidelines recommend a higher amount of protein. The aim of this study was to evaluate the safety of LPD treatment in older adults with advanced CKD.

Methods: The EQUAL study is a prospective, observational study including patients ≥65 years of age with an incident estimated glomerular filtration rate <20 ml/min/1.73 m2 in six European countries with follow-up through 6 years. Nutritional status was assessed by a 7-point subjective global assessment (SGA) every 3-6 months. Prescribed diet (g protein/kg of bodyweight) was recorded on every study visit; measured protein intake was available in three countries. Time to death and decline in nutritional status (SGA decrease of ≥2 points) were analysed using marginal structural models with dynamic inverse probability of treatment and censoring weights.

Results: Of 1738 adults (631 prescribed LPD at any point during follow-up), there were 1319 with repeated SGA measurements, of which 267 (20%) decreased in SGA ≥2 points and 565 (32.5%) who died. There was no difference in survival or decrease in nutritional status for patients prescribed a LPD ≤0.8 g/kg ideal bodyweight {odds ratio [OR] for mortality 1.15 [95% confidence interval (CI) 0.86-1.55)] and OR for decrease in SGA 1.11 [95% CI 0.74-1.66]} in the adjusted models. In patients prescribed a LPD <0.6 g/kg ideal bodyweight, the results were similar. There was a significant interaction with LPD and older age >75 years, lower SGA and higher comorbidity burden for both mortality and nutritional status decline.

Conclusions: In older adults with CKD approaching end-stage kidney disease, a traditional LPD prescribed and monitored according to routine clinical practice in Europe appears to be safe.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
晚期慢性肾病老年人低蛋白饮食的安全性。
背景:低蛋白饮食(LPD)被推荐给晚期慢性肾脏病(CKD)患者,而老年病指南则推荐较高的蛋白质量。本研究旨在评估晚期慢性肾脏病老年人接受低蛋白饮食治疗的安全性:EQUAL 研究是一项前瞻性观察研究,包括年龄≥65 岁的患者、事件估计肾小球滤过率:在 1738 名成人中(631 人在随访期间的任何时候服用了 LPD),有 1319 人重复测量了 SGA,其中 267 人(20%)的 SGA 下降了 2 个百分点,565 人(32.5%)死亡。在调整模型中,LPD ≤0.8 g/kg 理想体重的患者在存活率和营养状况下降方面没有差异(死亡率的比值比(OR)为 1.15(95% 置信区间(CI)为 0.86-1.55),SGA 下降的比值比(OR)为 1.11(95% 置信区间(CI)为 0.74-1.66)。在开具 LPD 75 年处方的患者中,SGA 较低,死亡率和营养状况下降的合并症负担较高:对于濒临终末期肾病的老年 CKD 患者,根据欧洲常规临床实践开具和监测的传统 LPD 似乎是安全的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Nephrology Dialysis Transplantation
Nephrology Dialysis Transplantation 医学-泌尿学与肾脏学
CiteScore
10.10
自引率
4.90%
发文量
1431
审稿时长
1.7 months
期刊介绍: Nephrology Dialysis Transplantation (ndt) is the leading nephrology journal in Europe and renowned worldwide, devoted to original clinical and laboratory research in nephrology, dialysis and transplantation. ndt is an official journal of the [ERA-EDTA](http://www.era-edta.org/) (European Renal Association-European Dialysis and Transplant Association). Published monthly, the journal provides an essential resource for researchers and clinicians throughout the world. All research articles in this journal have undergone peer review. Print ISSN: 0931-0509.
期刊最新文献
Determination of urine volume and glomerular filtration rate using d-serine and d-asparagine. Ethical considerations on the use of big Data and Artificial Intelligence in kidney research from the ERA ethics committee. Neutralizing the IL-7Rα limits injury in experimental ANCA-associated glomerulonephritis. Seasonal variations in the association between proteinuria, CKD, and kidney failure. CD38 ligation in sepsis promotes nicotinamide phosphoribosyltransferase-mediated IL-6 production in kidney stromal cells.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1